As of April 16, 2025, Kala Pharmaceuticals (KALA) has a market cap of $22.777 million USD. According to our data, Kala Pharmaceuticals is ranked No.8498 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $22.78 M |
-46.12%
|
Dec 31, 2024 | $42.27 M |
-0.86%
|
Dec 29, 2023 | $42.64 M |
-81.65%
|
Dec 30, 2022 | $0.23 B |
-36.94%
|
Dec 31, 2021 | $0.37 B |
-82.15%
|
Dec 31, 2020 | $2.06 B |
83.74%
|
Dec 31, 2019 | $1.12 B |
-24.54%
|
Dec 31, 2018 | $1.49 B |
-73.55%
|
Dec 29, 2017 | $5.63 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Alcon
ALC
|
$45.22 B |
-0.002 M
|
![]() Switzerland
|
![]() Bausch + Lomb
BLCO
|
$4.21 B |
0.000 M
|
![]() Canada
|
![]() Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
![]() USA
|
![]() Novartis
NVS
|
$217.12 B |
0.003 M
|
![]() Switzerland
|
![]() Pfizer
PFE
|
$127.27 B |
-0.003 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
![]() USA
|
![]() AbbVie
ABBV
|
$312.76 B |
-0.013 M
|
![]() USA
|
![]() Glaukos
GKOS
|
$5.35 B |
0.000 M
|
![]() USA
|
![]() Ocular Therapeutix
OCUL
|
$1.20 B |
-0.000 M
|
![]() USA
|
![]() EyePoint Pharmaceuticals
EYPT
|
$0.39 B |
-0.000 M
|
![]() USA
|
![]() Clearside Biomedical
CLSD
|
$63.40 M |
0.000 M
|
![]() USA
|
Market Cap | = | KALA Stock Price | * | KALA Shares Outstanding |
= | $3.53 | * | 6.45 M | |
= | $22.78 M |